These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8072175)

  • 1. [A study on nephrotoxicity of arbekacin and vancomycin in rats].
    Niizato T; Ohnishi M; Nishiyama S; Asaoka H; Saito A
    Jpn J Antibiot; 1994 Jun; 47(6):664-75. PubMed ID: 8072175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Attenuation of arbekacin-induced nephrotoxicity in rats by pazufloxacin mesilate].
    Kizawa K; Miyazaki M; Nagasawa M; Ogake N; Nagai A; Sanzen T; Kawamura Y
    Jpn J Antibiot; 2003 Feb; 56(1):44-54. PubMed ID: 12723398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibacteriological activities of arbekacin and vancomycin against strains of MRSA].
    Ishii T; Takayama Y; Takase Y; Orikasa Y
    Jpn J Antibiot; 1994 Jun; 47(6):647-54. PubMed ID: 8072173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination effect of arbekacin and cefepime on mixed culture of MRSA and P. aeruginosa].
    Araake M; Hara T; Miyata A; Tani M; Ogawa H
    Jpn J Antibiot; 2001 Feb; 54(2):69-78. PubMed ID: 11338680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. I. The combined effect of arbekacin with fosfomycin or clavulanic acid/ticarcillin].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1992 Aug; 45(8):949-57. PubMed ID: 1433901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of once-daily administration of arbekacin. Experimental study and determination of pharmacokinetic properties in man].
    Totsuka K; Shimizu K; Mitomi N; Niizato T; Araake M
    Jpn J Antibiot; 1994 Jun; 47(6):676-92. PubMed ID: 8072176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro studies on the combined effects of arbekacin and fosfomycin on methicillin-resistant Staphylococcus aureus].
    Watanabe T; Kanno M; Sobu K; Takase Y; Yoshida T
    Jpn J Antibiot; 1995 Feb; 48(2):284-92. PubMed ID: 7745817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal activity of arbekacin against methicillin-resistant Staphylococcus aureus. Comparison with that of vancomycin.
    Aoki Y
    Jpn J Antibiot; 1994 Jun; 47(6):640-6. PubMed ID: 8072172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group].
    Morimoto K; Nakatani S; Kaji M; Kinoshita H; Fujimoto M; Hirata S; Ueda T; Tamate S; Yamazaki O
    Jpn J Antibiot; 1994 Jun; 47(6):826-36. PubMed ID: 8072193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical efficacy of arbekacin on MRSA infections].
    Ichiyama S; Shimokata K
    Jpn J Antibiot; 1994 Jun; 47(6):731-5. PubMed ID: 8072181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of bactericidal activity of arbekacin in mixed culture with MRSA and Pseudomonas aeruginosa using an in vitro pharmacokinetic simulation system].
    Tsuji A; Sugano T; Yamaguchi K; Goto S; Takada T; Takase Y; Yoshida T
    Jpn J Antibiot; 1994 Jun; 47(6):655-63. PubMed ID: 8072174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibacterial activities of arbekacin against recently isolated methicillin-resistant Staphylococcus aureus (I)].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R
    Jpn J Antibiot; 1993 Mar; 46(3):234-41. PubMed ID: 8510320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. IV. Combined effects of arbekacin with cefmetazole or flomoxef].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1992 Oct; 45(10):1312-8. PubMed ID: 1479683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibiotic efficacies of combined uses of arbekacin and various antibiotics against methicillin-resistant Staphylococcus aureus].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1994 Jun; 47(6):693-700. PubMed ID: 8072177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. III. Combined effects of arbekacin with cefotiam or cefuzonam].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1992 Oct; 45(10):1305-11. PubMed ID: 1479682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of arbekacin and vancomycin on release of lactate dehydrogenase and fragmentation of DNA in LLC-PK1 kidney epithelial cells.
    Nakamura T; Kokuryo T; Okuda M; Hashimoto Y; Inui K
    Pharm Res; 1999 Jul; 16(7):1132-5. PubMed ID: 10450943
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. II. The combined effect of arbekacin with imipenem or cefminox].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1992 Aug; 45(8):958-64. PubMed ID: 1433902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nephrotoxicity and drug interaction of vancomycin (2)].
    Toyoguchi T; Nakagawa Y
    Nihon Yakurigaku Zasshi; 1996 May; 107(5):225-35. PubMed ID: 8690304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine.
    Oktem F; Arslan MK; Ozguner F; Candir O; Yilmaz HR; Ciris M; Uz E
    Toxicology; 2005 Nov; 215(3):227-33. PubMed ID: 16112787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antimicrobial activities of arbekacin against methicillin-resistant Staphylococcus aureus isolated from patients of a pediatrics ward].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1993 Sep; 46(9):794-800. PubMed ID: 8254899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.